Reneo Pharmaceuticals Correlations
RPHMDelisted Stock | USD 18.20 1.40 8.33% |
The current 90-days correlation between Reneo Pharmaceuticals and Cns Pharmaceuticals is 0.03 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reneo Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reneo Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Reneo Pharmaceuticals Correlation With Market
Significant diversification
The correlation between Reneo Pharmaceuticals and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Reneo Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Reneo |
Moving together with Reneo Stock
0.68 | OPTX | Syntec Optics Holdings Buyout Trend | PairCorr |
Moving against Reneo Stock
0.57 | WF | Woori Financial Group | PairCorr |
0.54 | KB | KB Financial Group | PairCorr |
0.45 | TOEYF | Toro Energy Limited | PairCorr |
0.39 | SHG | Shinhan Financial | PairCorr |
0.38 | PPERF | Bank Mandiri Persero | PairCorr |
0.38 | PPERY | Bank Mandiri Persero | PairCorr |
0.38 | PTBRY | Bank Negara Indonesia | PairCorr |
0.35 | PBCRY | Bank Central Asia | PairCorr |
0.35 | PLL | Piedmont Lithium | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Reneo Stock performing well and Reneo Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Reneo Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PRME | 4.00 | (0.35) | 0.00 | (0.13) | 0.00 | 7.74 | 25.80 | |||
DNA | 4.52 | 0.35 | 0.07 | 0.15 | 5.92 | 10.46 | 29.19 | |||
OCEA | 3.41 | (0.55) | 0.00 | (1.56) | 0.00 | 7.46 | 27.01 | |||
RPRX | 0.82 | (0.14) | 0.00 | (0.57) | 0.00 | 1.38 | 5.23 | |||
IMMX | 5.20 | 0.60 | 0.10 | 0.51 | 5.24 | 17.36 | 35.42 | |||
CNSP | 4.37 | (0.16) | 0.00 | (0.19) | 0.00 | 10.00 | 39.29 | |||
HEPA | 3.82 | (0.41) | 0.00 | (1.37) | 0.00 | 8.06 | 35.17 | |||
FRLN | 5.90 | (0.03) | 0.00 | 0.05 | 0.00 | 14.23 | 72.38 | |||
AVRO | 1.77 | 0.14 | 0.05 | 43.63 | 1.89 | 4.11 | 14.20 | |||
SMMT | 3.86 | (0.32) | 0.00 | (0.38) | 0.00 | 7.85 | 24.11 |
Delisting Warning - RPHM
Reneo Pharmaceuticals was delisted
The entity Reneo Pharmaceuticals with a symbol RPHM was delisted from NASDAQ Exchange. Please try OnKure Therapeutics, with a symbol OKUR from now on. Check all delisted instruments accross multiple markets. |
Reneo Pharmaceuticals Corporate Management
Alejandro MD | Chief Officer | Profile | |
Ashley JD | Chief Officer | Profile | |
Wendy MBA | Consultant | Profile | |
Vineet Jindal | Consultant | Profile | |
Michael Cruse | Chief Officer | Profile | |
Jennifer Lam | Principal Officer | Profile |
Still Interested in Reneo Pharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.